[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pregnant-hiv-positive-women\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pregnant-hiv-positive-women":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100644146","bridges-an-hiv-doula-program-100644146",false,"NCT07664423","BRIDGES: An HIV Doula Program","BRIDGES: A Patient-Centered, Community-Informed HIV Doula Program That Supports Infant Feeding Choice","Inclusion Criteria:\n\n* Pregnant and postnatal women, followed at the institutional clinic for women with HIV\n* \\> = 18 years old, with an HIV diagnosis\n* Pregnant or postnatal\n* Reside in South Florida\n* Able to communicate at the 6th grade level in English, Spanish or Haitian Creole.\n\nExclusion Criteria:\n\n* Under 18\n* Not able to read\u002Fwrite English, Spanish or Haitian Creole at the 6th grade level","FEMALE","18 Years",{"count":19,"type":20},15,"ESTIMATED","INTERVENTIONAL",[23],"NA","The purpose of BRIDGES (BReast and Infant feeding Doulas to address Gaps in Education and Support) is to develop, test and disseminate an HIV Doula education and support program to improve maternal\u002Fchild health outcomes and reduce perinatal transmission.",[26],"Pregnant HIV Positive Women",[28,29,30],"Doula","Infant Feeding","HIV","NOT_YET_RECRUITING","2026-06-17",{"date":34,"type":35},"2026-06-24","ACTUAL",{"date":37,"type":20},"2026-09",{"date":39,"type":20},"2027-09",{"name":41,"class":42},"University of Miami","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":16,"minAge":53,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":21,"phases":56,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":43},"100614350","tb-screening-improves-preventive-therapy-uptake-in-pregnant-women-with-hiv-100614350","NCT07278453","TB SCReening Improves Preventive Therapy Uptake in Pregnant Women With HIV","Optimal Tuberculosis Screening and Tuberculosis Preventive Therapy Delivery Strategies to Improve Maternal and Birth Outcomes Among Pregnant Women With HIV in Uganda: a Randomized Trial","TB SCRIPT-Moms","For the TB screening trial, eligible patients include pregnant women with a viable singleton pregnancy by ultrasound, confirmed HIV infection, no current or planned TB treatment, no treatment with a drug with anti-mycobacterial activity within the past 2 weeks, no history of TB treatment or TPT within the past 2 years, lives within 20 km of the enrollment site, plans to deliver at the enrollment site, no plans to transfer antenatal care to a non-participating clinic, and no signs or symptoms of early or active labor.\n\nFor the TPT delivery trial, eligible participants are participants in the TB screening trial who screened negative for TB by their randomization assignment, are eligible for TPT, are not taking any drug contraindicated for use with rifamycins, are not a contact with a TB case with known drug resistance to isoniazid or rifampin, are not heavy or binge alcohol consumers, do not have a history of liver disease, do not have liver enzymes ≥3-times the upper limit of normal.",true,"16 Years",{"count":55,"type":20},1500,[23],"Because pregnant women have been excluded from clinical research, including tuberculosis (TB) research, little is known about diagnosing, treating and preventing TB in pregnant women. We plan to perform a two-stage randomized trial that will identify best practices for screening pregnant and postpartum women for active TB (screening by symptoms vs. C-reactive protein levels) and the optimal timing of TPT initiation, relative to pregnancy (immediately during pregnancy or deferred to postpartum). Because undiagnosed TB among pregnant women with HIV is associated with many devastating complications to both the mother and fetus, this research has the potential to improve maternal and birth outcomes worldwide.",[26,30,59],"Tuberculosis (TB)",[61,62,63,64,65,66],"pregnant women with HIV","pregnant women","hiv","tuberculosis","screening","tuberculosis preventive therapy","2025-12-02",{"date":69,"type":35},"2025-12-12",{"date":71,"type":20},"2026-06",{"date":73,"type":20},"2031-06",{"name":75,"class":42},"University of California, San Francisco"]